Compounds > phosphorylcholine

phosphorylcholine and sphingosyl beta-glucoside

phosphorylcholine has been researched along with sphingosyl beta-glucoside in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (77.78)	29.6817
2010's	1 (11.11)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Kanazawa, T; Kawasaki, T; Kozutsumi, Y; Momoi, M; Nakamura, S; Sabe, H; Takematsu, H; Yamaji, T; Yamamoto, A; Yano, H	1
Bischoff, A; Czyborra, P; Fetscher, C; Jakobs, KH; Meyer Zu Heringdorf, D; Michel, MC	1
Bischoff, A; Czyborra, P; Jakobs, KH; Meyer Zu Heringdorf, D; Michel, MC	1
Arikawa, J; Imokawa, G; Ishibashi, M; Kawashima, M; Okamoto, R; Takagi, Y	1
Deguchi, H; Griffin, JH; Yegneswaran, S	1
Damirin, A; Hashimoto, K; Komachi, M; Kon, J; Mogi, C; Okajima, F; Sato, K; Tobo, M; Tomura, H; Wang, JQ	1
Imokawa, G	1
Amraoui, Y; Garzotti, M; Groenen, P; Kolb, SA; Marquardt, T; Marques Lourenço, C; Mengel, E; Morand, O; Reunert, J; Welford, RW	1
Alayoubi, A; Auray-Blais, C; Boutin, M; Menkovic, I; Mercier, FE; Rivard, GÉ	1

Reviews

1 review(s) available for phosphorylcholine and sphingosyl beta-glucoside

Article	Year
A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Journal of dermatological science, 2009, Volume: 55, Issue:1 Topics: Amidohydrolases; Ceramides; Dermatitis, Atopic; Epidermis; Glucosylceramides; Humans; Phosphorylcholine; Psychosine; Sphingomyelins; Sphingosine	2009

Other Studies

8 other study(ies) available for phosphorylcholine and sphingosyl beta-glucoside

Article	Year
Inhibition of cytokinesis by a lipid metabolite, psychosine. The Journal of cell biology, 2000, May-15, Volume: 149, Issue:4 Topics: Actins; Cell Division; Humans; Leukodystrophy, Globoid Cell; Phagocytosis; Phosphorylcholine; Psychosine; Sphingosine; Tumor Cells, Cultured; U937 Cells	2000
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. British journal of pharmacology, 2000, Volume: 130, Issue:8 Topics: Animals; Calcium; Dose-Response Relationship, Drug; Egtazic Acid; In Vitro Techniques; Indomethacin; Lysophospholipids; Male; Mesenteric Arteries; Nitrendipine; Nitroarginine; Pertussis Toxin; Phosphorylcholine; Psychosine; Rats; Rats, Wistar; Renal Artery; Sphingosine; Vasoconstriction; Vasodilator Agents; Virulence Factors, Bordetella	2000
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. British journal of pharmacology, 2000, Volume: 130, Issue:8 Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Kidney; Lysophospholipids; Male; Mesentery; Pertussis Toxin; Phosphorylcholine; Psychosine; Rats; Rats, Wistar; Renal Circulation; Sphingosine; Splanchnic Circulation; Virulence Factors, Bordetella	2000
Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. Journal of lipid research, 2003, Volume: 44, Issue:1 Topics: Adolescent; Adult; Ceramides; Dermatitis, Atopic; Epidermis; Humans; Phosphorylcholine; Psychosine; Sphingosine; Up-Regulation	2003
Sphingolipids as bioactive regulators of thrombin generation. The Journal of biological chemistry, 2004, Mar-26, Volume: 279, Issue:13 Topics: Anticoagulants; Binding Sites; Blood Platelets; Carbon; Dose-Response Relationship, Drug; Down-Regulation; Factor Va; Factor Xa; Gene Expression Regulation; Humans; Inhibitory Concentration 50; Lipid Metabolism; Lipids; Micelles; Phosphorylcholine; Protein Binding; Protein Structure, Tertiary; Prothrombin; Psychosine; Sphingolipids; Sphingosine; Thrombin	2004
Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. Journal of pharmacological sciences, 2005, Volume: 99, Issue:2 Topics: Adenylyl Cyclases; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Inositol Phosphates; Lysophosphatidylcholines; Phosphorylcholine; Psychosine; Receptors, G-Protein-Coupled; Second Messenger Systems; Sphingosine; Transfection; Type C Phospholipases	2005
Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. PloS one, 2014, Volume: 9, Issue:12 Topics: Adolescent; Adult; Aged; Biomarkers; Blood Specimen Collection; Case-Control Studies; Edetic Acid; Female; Heparin; Humans; Male; Niemann-Pick Disease, Type C; Phosphorylcholine; Psychosine; Reproducibility of Results; Retrospective Studies; Sphingosine; Tandem Mass Spectrometry; Young Adult	2014
Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach. International journal of molecular sciences, 2020, Oct-23, Volume: 21, Issue:21 Topics: Adult; Aged; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Early Diagnosis; Female; Gaucher Disease; Humans; Male; Mass Spectrometry; Metabolomics; Middle Aged; Phosphorylcholine; Prognosis; Psychosine; Sensitivity and Specificity; Sphingosine; Young Adult	2020